Paper8097632
Clinical significance of P-glycoprotein in multidrug resistance malignancies.
Arceci RJ. Blood, 1993. Cited by 236 papers, by iCite.
Cite this record
ConductScience Library. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Papers, record 8097632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097632
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance | Major topic |
| Membrane Glycoproteins | Major topic |
| Neoplasms | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Adult | |
| Animals | |
| Antineoplastic Agents | |
| Child | |
| Humans | |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
| Prognosis | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA48162 | NCI NIH HHS | United States | R01CA048162 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00011414 | Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 7902138 | Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay. | https://conductscience.org/library/papers/7902138 |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33198344 | Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33198344 | PubMed |
| 32581566 | Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review. | Pharmgenomics Pers Med | 2020 | https://conductscience.org/library/papers/32581566 | PubMed |
| 30579343 | Genetic and molecular origins of colorectal Cancer among the Iranians: an update. | Diagn Pathol | 2018 | https://conductscience.org/library/papers/30579343 | PubMed |
| 29948283 | Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid. | Arch Dermatol Res | 2018 | https://conductscience.org/library/papers/29948283 | PubMed |
| 28353592 | The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28353592 | PubMed |
| 27916761 | CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? -inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from the rat brain and its optimal route of administration. | J Vet Med Sci | 2017 | https://conductscience.org/library/papers/27916761 | PubMed |
| 26486517 | Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors. | Cancer Chemother Pharmacol | 2015 | https://conductscience.org/library/papers/26486517 | PubMed |
| 26354214 | Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase. | Indian J Med Res | 2015 | https://conductscience.org/library/papers/26354214 | PubMed |
| 26222892 | N-(2-Hydroxypropyl)methacrylamide Copolymer-Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia. | Macromol Biosci | 2016 | https://conductscience.org/library/papers/26222892 | PubMed |
| 25947324 | Effect of cyclosporin on distribution of methotrexate into the brain of rats. | J Vet Med Sci | 2015 | https://conductscience.org/library/papers/25947324 | PubMed |
| 25378644 | Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/25378644 | PubMed |
| 23762410 | An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23762410 | PubMed |
| 22038456 | Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia. | J Appl Genet | 2012 | https://conductscience.org/library/papers/22038456 | PubMed |
| 21380926 | The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. | Int J Hematol | 2011 | https://conductscience.org/library/papers/21380926 | PubMed |
| 20528455 | Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. | Nanomedicine (Lond) | 2010 | https://conductscience.org/library/papers/20528455 | PubMed |
| 20298675 | Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy. | Biochem Pharmacol | 2010 | https://conductscience.org/library/papers/20298675 | PubMed |
| 20209646 | Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. | Pediatr Blood Cancer | 2010 | https://conductscience.org/library/papers/20209646 | PubMed |
| 20147974 | Chronic myeloid leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 activity. | Leukemia | 2010 | https://conductscience.org/library/papers/20147974 | PubMed |
| 20127181 | Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. | Mol Biol Rep | 2011 | https://conductscience.org/library/papers/20127181 | PubMed |
| 15239391 | Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease. | Int J Hematol | 2004 | https://conductscience.org/library/papers/15239391 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8097632
GET https://conductscience.org/api/papers/v1/8097632/cited_by?page=2